NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹8.97 Cr | ₹28 Cr | ₹91 Cr | ₹75 Cr | ₹105 Cr |
What is the latest Contingent Liabilities ratio of NEULAND LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹8.97 Cr |
| Mar2024 | ₹28 Cr |
| Mar2023 | ₹91 Cr |
| Mar2022 | ₹75 Cr |
| Mar2021 | ₹105 Cr |
How is Contingent Liabilities of NEULAND LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.97 Cr | -67.65 | |
| Mar2024 | ₹28 Cr | -69.60 | |
| Mar2023 | ₹91 Cr | 22.14 | |
| Mar2022 | ₹75 Cr | -28.68 | |
| Mar2021 | ₹105 Cr | - | |
Compare Contingent Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹15,548.8 Cr | -3.7% | -7.8% | 4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -3.7% |
-7.8% |
4% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses